Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.7431
+0.0105 (1.43%)
At close: Jun 27, 2025, 4:00 PM
0.7400
-0.0031 (-0.42%)
After-hours: Jun 27, 2025, 5:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Human Pharmaceutical Products
257.24M
Log In
Log In
Log In
Log In
Upgrade
Human Pharmaceutical Products Growth
21.89%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
257.24M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
21.89%
Log In
Log In
Log In
Log In
Upgrade